Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking Wegovy every 6 days instead of 7 is not recommended. Wegovy (semaglutide) is licensed as a once-weekly injection, meaning each dose is designed to cover exactly seven days. Injecting a day early changes the interval in ways that aren't clinically validated, and the prescriber who approved your treatment hasn't sanctioned it. If a scheduling conflict is pushing you toward a 6-day window, there is a better-supported path — and it's worth understanding why the 7-day interval exists before deciding what to do. Wegovy is a prescription-only medicine; timing decisions belong with your prescribing team, not to personal trial-and-error.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide has a plasma half-life of roughly one week. That biology is precisely why the weekly injection schedule exists: the drug accumulates steadily over the first several doses, reaching a stable concentration that suppresses appetite and slows gastric emptying consistently across all seven days. Compress the interval to six days and you're re-dosing before the previous injection has fully run its course. Over time, that shortfall of 24 hours per cycle adds up (roughly four extra doses per year) raising cumulative exposure beyond what the clinical trials tested.
The NHS medicines page for semaglutide is clear that Wegovy is a once-weekly injection, and the SmPC published on the eMC reinforces that the interval should be at least five days and ideally consistent. That minimum of five days is a safeguard for the occasional missed-day situation, not a routine target. Six days sits in a grey zone: technically above the five-day floor, but below the intended interval.
A question our prescribers hear most weeks is some version of: "I injected Monday last week and I'll be travelling on Sunday, can I do it Saturday instead?" That's a legitimate practical concern, and it has a legitimate answer. If you are curious whether taking semaglutide every five days is ever appropriate, the short answer is that a one-off shift is very different from routinely injecting every six days.
The Wegovy Patient Information Leaflet allows you to move your weekly injection day if needed, provided at least five days have elapsed since the previous dose. So if your usual day is Monday and you need to inject on Sunday this week, that's permitted once in a while. What isn't supported is resetting your schedule so that every injection comes six days after the last, that turns a flexibility provision into a different dosing regimen altogether.
There's also a practical cost to early dosing: side effects on Wegovy tend to cluster in the first day or two after each injection, as the new dose peaks. If you inject six days apart rather than seven, those peaks arrive more frequently. Nausea, indigestion and fatigue (the most common GI effects) may feel more persistent rather than settling between doses. Our Wegovy overview covers the full side-effect picture in detail.
If your schedule genuinely makes every-six-day injection feel necessary (shift work, travel patterns, injection-day commitments) the right move is to pick a new consistent weekly day and shift to it properly, using the one-off transition the leaflet allows, then stick to seven-day intervals from there.
If you've taken one dose at the six-day mark rather than seven, there's no need for alarm. The five-day minimum means you haven't violated the licensed schedule's lower boundary. Carry on with your usual weekly day from that point. If you've been routinely injecting every six days for several weeks, raise it with your prescriber at the next review, not because anything catastrophic is likely, but because your prescriber's clinical picture of your treatment is based on a weekly schedule, and consistent deviations are worth flagging.
Timing questions also become more important as doses increase. Jumping from one strength to the next is already a bigger physiological step; adding compressed intervals on top isn't advisable. The semaglutide treatment information on our site explains how titration works and why each stage matters. For readers wondering about other interval variations, there's further reading on taking Wegovy every 10 days and on extending to a two-week gap, both raise different clinical considerations.
Cost pressures sometimes drive people toward stretching or compressing doses. If that's the situation, it's worth looking at what's actually included in the price of a private prescription, our Wegovy pricing page sets out the full picture. Skipping days or doubling up to make pens last longer creates a different set of risks and is not something any prescriber would endorse.
There are situations where timing becomes less relevant than getting clinical advice promptly. If you're injecting early because the previous dose caused severe nausea, vomiting or persistent abdominal pain, that's a signal to contact your prescriber rather than adjust the schedule. Severe, persistent stomach pain that radiates to the back warrants urgent medical attention, as pancreatitis is a known though infrequent risk flagged in MHRA safety guidance. Dehydration from repeated vomiting or diarrhoea should also be assessed quickly, it can affect kidney function, especially at higher doses.
Suspected side effects can be reported via the MHRA's Yellow Card scheme, which helps regulators monitor how medicines perform in real-world use. It's open to patients as well as healthcare professionals. If you're on a treatment plan that doesn't feel right, reach out to our team directly, aftercare is part of what's included, seven days a week.
Timing issues are also worth discussing if you're considering whether Wegovy is still the right treatment for you. Our weight-loss treatment overview covers the broader options for adults in the UK.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.